Importantly, coadministration of anti-CHI3L1 significantly lessened the white matter lesions in the focal NMO rat model (Supplemental Figure 3G), demonstrating the efficacy of anti-CHI3L1 in attenuating demyelination detectable by clinical imaging modalities. This evidence concerns the gene CHI3L1 and neuromyelitis optica.